CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-05-20 | CASTALDI DAVID L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2010-05-20 | COX GEOFFREY F Director | Purchase | +1,908 | $5.24 | $10K | 25,679 |
| 2010-05-20 | COX GEOFFREY F Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −300 | $5.68 | $2K | 112,952 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −50 | $5.69 | $284 | 112,902 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −850 | $5.69 | $5K | 112,052 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,000 | $5.70 | $6K | 111,052 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −3,205 | $5.70 | $18K | 107,847 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −700 | $5.71 | $4K | 107,147 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −3,592 | $5.71 | $21K | 103,555 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −100 | $5.72 | $572 | 103,455 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,900 | $5.72 | $11K | 101,555 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −100 | $5.73 | $573 | 101,455 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,400 | $5.73 | $8K | 100,055 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,003 | $5.74 | $6K | 99,052 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −600 | $5.75 | $3K | 98,452 |
| 2010-05-17 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −200 | $5.76 | $1K | 98,252 |
| 2010-04-13 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Sale | −2,250 | $5.78 | $13K | 47,350.1 |
| 2010-04-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −200 | $5.30 | $1K | 118,300 |
| 2010-04-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −928 | $5.31 | $5K | 117,372 |
Page 29 of 42 · 830 trades